Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
184
Música para piano
68
Indígenas de México
57
Política y gobierno
54
Condiciones sociales
50
Jazz
46
Química
45
Condiciones económicas
39
Música instrumental
38
Sinfonías
31
Física
30
Estudio y enseñanza
29
Manuales
28
Música popular
28
Ingeniería
26
Leyes y legislación
26
Operas
25
Problemas, ejercicios, etc
25
Administración municipal
24
Enfermería
24
Antigüedades
22
Música orquestal
22
Química orgánica
22
Electrónica
21
Música
21
Conciertos (Piano)
20
Español
20
Historia y crítica
20
Matemáticas
20
Poesía mexicana
20
-
173661por Leston, Meredith, Elson, William H, Watson, Conall, Lakhani, Anissa, Aspden, Carole, Bankhead, Clare R, Borrow, Ray, Button, Elizabeth, Byford, Rachel, Elliot, Alex J, Fan, Xuejuan, Hoang, Uy, Linley, Ezra, Macartney, Jack, Nicholson, Brian D, Okusi, Cecilia, Ramsay, Mary, Smith, Gillian, Smith, Sue, Thomas, Mark, Todkill, Dan, Tsang, Ruby SM, Victor, William, Williams, Alice J, Williams, John, Zambon, Maria, Howsam, Gary, Amirthalingam, Gayatri, Lopez-Bernal, Jamie, Hobbs, F D Richard, de Lusignan, Simon“…We further describe influenza and COVID-19 vaccine coverage for the 2020-2021 season (week 40 of 2020 to week 39 of 2021), with the latter differentiated by vaccine brand. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173662por Mahtani, Reshma, Niyazov, Alexander, Arondekar, Bhakti, Lewis, Katie, Rider, Alex, Massey, Lucy, Lux, Michael Patrick“…On the EORTC QLQ-C30 functional scales, patients receiving PARPi reported significantly better scores (mean ± SE) for physical functioning (80.0 ± 2.4 vs 71.9 ± 3.4; p < 0.05) and social functioning (82.0 ± 6.2 vs 63.6 ± 3.7; p < 0.05) and, on the symptom scales, reported significantly better scores for constipation (1.9 ± 1.8 vs 18.7 ± 3.2; p < 0.001), breast symptoms (0.4 ± 3.9 vs 13.3 ± 2.6; p < 0.01), arm symptoms (2.6 ± 1.3 vs 11.4 ± 2.4; p = 0.001), and systemic therapy side effects (13.5 ± 1.8 vs 29.4 ± 2.3; p < 0.001). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173663por Gellen, Barnabas, Thorin‐Trescases, Nathalie, Thorin, Eric, Gand, Elise, Ragot, Stephanie, Montaigne, David, Pucheu, Yann, Mohammedi, Kamel, Gatault, Philippe, Potier, Louis, Liuu, Evelyne, Hadjadj, Samy, Saulnier, Pierre‐Jean, Hadjadj, Samy, Marechaud, Richard, Ragot, Stéphanie, Piguel, Xavier, Saulnier, Pierre‐Jean, Javaugue, Vincent, Gand, Elise, Hulin‐Delmotte, Charlotte, Llatty, Pierre, Ducrocq, Gregory, Roussel, Ronan, Rigalleau, Vincent, Pucheu, Yann, Zaoui, Philippe, Montaigne, David, Halimi, Jean‐Michel, Gatault, Philippe, Sosner, Philippe, Gellen, Barnabas“…In the remaining 1258 patients, the association of serum S100A12 with the risk of HHF tended to be more pronounced [1.39 (1.06–1.83)]. When including the gold standard HF marker NT‐proBNP in the model, the prognostic value of S100A12 for HHF did not reach significance. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173664por de Souza, Mailza Gonçalves, Reis, Irene Alexandre, de Carvalho, Isabela Pena Carvalho, Porcionato, Marco Aurélio De Felicio, Prados, Laura Franco, Granja-Salcedo, Yury Tatiana, Siqueira, Gustavo Rezende, de Resende, Flávio Dutra“…The evaluated treatments were 1: (TP-U) (control) = supplement with 24% crude protein (CP) containing urea as a source of non-protein nitrogen (NPN; 3%) and soybean meal, 2: (TP-PRU) = 24% CP supplement containing post-ruminal urea (PRU; 3.6%) and soybean meal; 3: (NPN-U-PRU) = 24% CP supplement containing urea + post-ruminal urea (U = 3% and PRU = 3.9%), without soybean meal; 4: (NPN-PRU) = supplement with 24% CP containing post-ruminal urea (7.5%), without soybean meal. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173665por Holm, P, Haue, A D, Westergaard, D, Banasik, K, Koeber, L, Brunak, S, Bundgaard, H“…We developed and externally validated PMHnet-alpha, a neural-network based survival model for risk-stratification in ischemic heart disease that leverages the multitude of clinical features available in modern electronical health records. METHODS: We included 39,746 IHD patients from the regional Heart Registry that had been subjected to a coronary angiography between 2006 and 2017 with confirmed coronary artery disease. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173666por Iglesias, D, Mazon-Ramos, P M R, Portela-Romero, M P R, Lopez-Barreiro, L L B, Garcia-Castelo, A G C, Pazos-Mareque, J P M, Rey-Aldana, D R A, Alvarez-Alvarez, B A A, Martinez-Monzonis, A M M, Cinza-Sanjurjo, S C S, Gonzalez-Juanatey, R G J“…The patients evaluated via e-consultation had less mortality (2.5% vs 3.9%, p<0.001), Figure 2. CONCLUSIONS: An outpatient care program that includes an e-consultation has shown to reduce waiting times significantly and is a safe model with a lower rate of mortality over the first year after the consultation. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173667“…On multivariate analysis, AI ML model driven mAFA-based upstream risk factor control significantly reduced the changes in AF burden of both Δ 6 month (adjusted OR, 95% CI, 0.51,0.43–0.59) and Δ 12 month (0.39,0.32–0.47, all p<0.001). CONCLUSION: mHealth-AF care increased the adherence of using smart devices for AF detection. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173668por Garcia-Zamora, S, Pulido, L, Antoniolli, M, Garcia, D, Perez, G, Priotti, M, Zaidel, E, Lopez-Santi, R, Vazquez, G, Chango-Azanza, D X, Nunez-Mendez, R, Cabral, L T, Sosa-Liprandi, A, Miranda-Arboleda, A F, Baranchuk, A“…Among the participants, 54.8% reported acts of violence: 95.6% suffered verbal violence, 11.1% physical violence, and 19.9% other types. 39.5% of respondents experienced it at least once a week. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173669“…After 12 months, compared with the control group, the intervention group saw the following metrics significantly reduced: systolic blood pressure (SBP) (131.66±9.43 vs 137.20±12.02 mmHg, P=0.000), total cholesterol (TC) (3.65±0.79 vs 4.08±0.82 mmol/L, P=0.001), low density lipoprotein cholesterol (LDL-C) (2.06±0.53 vs 2.38±0.61 mmol/L, P=0.002), and fasting blood glucose (FBG) (6.26±0.75 vs 6.81±0.97 mmol/L, P=0.000), while the following metrics went up significantly: blood pressure control rate (77.3% vs 59.1%, P=0.039), blood lipid control rate(39.4% vs 21.2%, P=0.037), glycemic control rate (71.2% vs 51.5%, P=0.031), and medication adherence score (7.10±0.77 vs 6.80±0.73, P=0.020). …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173670“…Zio monitoring was associated with a significant reduction in the need for OPAs for fitting (0.5% vs. 96%, p<0.001) and follow-up (70.1% vs. 87.0, p<0.001), and resulted in a significant increase in ablations (5.9% vs. 1.0%, p=0.005) but not device implantations (5.9% vs. 3.9, p=0.209). CONCLUSION: Our findings indicate that Zio XT is associated with a statistically significant reduction in time to results, higher arrhythmia detection rate and a reduced need for OPAs. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173671por Holm Nielsen, Signe, Sun, Shu, Bay-Jensen, Anne C., Karsdal, Morten, Sørensen, Inge Juul, Weber, Ulrich, Loft, Anne Gitte, Kollerup, Gina, Thamsborg, Gorm, Madsen, Ole Rintek, Møller, Jakob, Østergaard, Mikkel, Pedersen, Susanne Juhl“…RESULTS: Patients were mostly males (82%), HLA-B27 positive (84%), with a median age of 40 years (IQR: 32–48), disease duration of 5.5 years (IQR: 2–10), and a baseline Ankylosing Spondylitis Disease Activity Score (ASDAS) of 3.9 (IQR: 3.0–4.5). Compared to baseline, PRO-C1 levels were significantly increased after two weeks of treatment, C6M levels were significantly decreased after two and 22 weeks (repeated measures ANOVA, p=0.0014 and p=0.0015, respectively), EL-NE levels were significantly decreased after 2 weeks (p=0.0008), VICM levels were significantly decreased after two and 22 weeks (p=0.0163 and p=0.0374, respectively), and CRP were significantly decreased after two and 22 weeks (both p=0.0001). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173672por Boily, Marie-Claude, Barnabas, Ruanne V., Rönn, Minttu M., Bayer, Cara J., van Schalkwyk, Cari, Soni, Nirali, Rao, Darcy W., Staadegaard, Lisa, Liu, Gui, Silhol, Romain, Brisson, Marc, Johnson, Leigh F., Bloem, Paul, Gottlieb, Sami, Broutet, Nathalie, Dalal, Shona“…Adding three-yearly cervical screening among WLHIV (to girls' vaccination and 2 lifetime cervical screens) further reduced age-standardised cervical cancer incidence to 3.3 (1.8–3.6) per 100,000 women-years overall and to 5.2 (3.9–8.5) among WLHIV by 2120 and averted on average 12–13% additional cumulative cancer cases among all women and 21–24% among WLHIV than girls’ vaccination and 2 lifetime cervical screens over 25 years or longer. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173673por Choon, Siew Eng, Wright, Alison K., Griffiths, Christopher E.M., Tey, Kwee Eng, Wong, Kit Wan, Lee, Yoong Wei, Suvelayutnan, Ushananthiny, Mariapun, Jeevitha, Ashcroft, Darren M.“…Rates were higher in males; the prevalence was 0·39% (0·37–0·41) in males and 0·29% (0·27–0·30) in females, and the respective incidences per 100 000 person‐years were 40·7 (38·2–43·2) and 28·3 (26·4–30·3). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173674por Mavranezouli, Ifigeneia, Daly, Caitlin H., Welton, Nicky J., Deshpande, Shalmali, Berg, Laura, Bromham, Nathan, Arnold, Stephanie, Phillippo, David M., Wilcock, Jane, Xu, Jingyuan, Ravenscroft, Jane C., Wood, Damian, Rafiq, Mohammed, Fou, Linyun, Dworzynski, Katharina, Healy, Eugene“…For mild‐to‐moderate acne, the most effective options for each treatment type were as follows: topical pharmacological – combined retinoid with benzoyl peroxide (BPO) [mean difference 26·16%, 95% credible interval (CrI) 16·75–35·36%]; physical – chemical peels, e.g. salicylic or mandelic acid (39·70%, 95% CrI 12·54–66·78%) and photochemical therapy (combined blue/red light) (35·36%, 95% CrI 17·75–53·08%). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173675por Wong, Martin C. S., Huang, Junjie, Wang, Harry H. X., Yuan, Jinqiu, Xu, Wanghong, Zheng, Zhi-Jie, Xue, Hao, Zhang, Lin, Jiang, Johnny Y., Huang, Jason L. W., Chen, Ping, Jia, Zhihui, Palaganas, Erlinda, Viwattanakulvanid, Pramon, Somrongthong, Ratana, Caicedo, Andrés, Medina-Arellano, María de Jesús, Murphy, Jill, Paredes, Maria B. A., Withers, Mellissa“…. = 1.19–2.04) and more than two (aOR = 2.32, 95% C.I. = 1.59–3.39) medical conditions were associated with low resilience level. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173676por Yang, Xihua, Ni, Hanghang, Lu, Zhan, Zhang, Jie, Zhang, Qian, Ning, Shangwu, Qi, Lunan, Xiang, Bangde“…RESULTS: Of the 105 patients, 50 were positive for M-CTCs (count ≥ 1 per 5 mL) and 39 showed high Ki67 expression (≥ 50% tumor cells were Ki67-positive). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173677por Katzdobler, Sabrina, Nitschmann, Alexander, Barthel, Henryk, Bischof, Gerard, Beyer, Leonie, Marek, Ken, Song, Mengmeng, Wagemann, Olivia, Palleis, Carla, Weidinger, Endy, Nack, Anne, Fietzek, Urban, Kurz, Carolin, Häckert, Jan, Stapf, Theresa, Ferschmann, Christian, Scheifele, Maximilian, Eckenweber, Florian, Biechele, Gloria, Franzmeier, Nicolai, Dewenter, Anna, Schönecker, Sonja, Saur, Dorothee, Schroeter, Matthias L., Rumpf, Jost-Julian, Rullmann, Michael, Schildan, Andreas, Patt, Marianne, Stephens, Andrew W., van Eimeren, Thilo, Neumaier, Bernd, Drzezga, Alexander, Danek, Adrian, Classen, Joseph, Bürger, Katharina, Janowitz, Daniel, Rauchmann, Boris-Stephan, Stöcklein, Sophia, Perneczky, Robert, Schöberl, Florian, Zwergal, Andreas, Höglinger, Günter U., Bartenstein, Peter, Villemagne, Victor, Seibyl, John, Sabri, Osama, Levin, Johannes, Brendel, Matthias“…METHODS: Seventy-eight patients with 4RTs (71 ± 7 years, 39 female), 79 patients with other neurodegenerative diseases (67 ± 12 years, 35 female) and twelve age-matched controls (69 ± 8 years, 8 female) underwent dynamic (0–60 min) [(18)F]PI-2620 PET imaging. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173678por Zaibi, H., Ouertani, H., Chaabi, K., Ben Jemia, E., Ben Amar, J., Aissa, W., Aouina, H.“…La détérioration clinique a été notée chez 154 patients (39,2 %) avec un transfert en milieu de réanimation pour 91 patients (23,2 %). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173679por Pierre, C., Goter, T., Lena, H., Chabot, G., Le Garff, G., Leveiller, G., Briens, E., Tiercin, M., Angibaud, A., Le Guen, Y., Ricordel, C.“…La durée médiane de suivi sous double immunothérapie était de 7 mois. Au total, 36/91(39,5 %) patients ont présenté ou ont maintenu une réponse partielle avec le schéma double dose ; 8/91 (8,7 %) ont présenté ou ont maintenu une réponse complète ; 29/91 (31,8 %) ont arrêté le schéma double dose pour progression. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
173680por Peterson, Alan L., Blount, Tabatha H., Foa, Edna B., Brown, Lily A., McLean, Carmen P., Mintz, Jim, Schobitz, Richard P., DeBeer, Bryann R., Mignogna, Joseph, Fina, Brooke A., Evans, Wyatt R., Synett, Samantha, Hall-Clark, Brittany N., Rentz, Timothy O., Schrader, Christian, Yarvis, Jeffrey S., Dondanville, Katherine A., Hansen, Hunter, Jacoby, Vanessa M., Lara-Ruiz, Jose, Straud, Casey L., Hale, Willie J., Shah, Dhiya, Koch, Lauren M., Gerwell, Kelsi M., Young-McCaughan, Stacey, Litz, Brett T., Meyer, Eric C., Blankenship, Abby E., Williamson, Douglas E., Roache, John D., Javors, Martin A., Sharrieff, Allah-Fard M., Niles, Barbara L., Keane, Terence M.“…RESULTS: Among 319 military personnel and veterans screened, 234 were randomized (mean [SD] age, 39.20 [7.72] years; 182 [78%] male participants), with 117 participants randomized to IOP-PE and 117 participants randomized to massed-PE. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto